Patients with rheumatoid arthritis all have a unique and diverse set of antibodies that are involved in the development of the disease. Researchers unveiled the complexity of these antibodies using powerful lab tools and challenge current therapeutic approaches.
The International Agency for Research on Cancer (IARC), the cancer agency of the World Health Organization (WHO), has established their priorities for the evaluation of carcinogens.
Join us at the AIBIA conference at the Jaarbeurs on Wednesday 15 May. The focus is on research and application of AI in the field of imaging in Life Sciences research.
How do we improve care for patients with rare diseases for which there are currently no treatments? This question is central to the work of pediatrician Sabine Fuchs.
Join us at the AIBIA conference at the Jaarbeurs on Wednesday 15 May. The focus is on research and application of AI in the field of imaging in Life Sciences research.